云南白药：全资子公司拟6.6亿元收购聚药堂100%股权

Core Viewpoint - Yunnan Baiyao announced the acquisition of 100% equity in An Guo Shi Ju Yao Tang Pharmaceutical Co., Ltd. for a total consideration of 660 million yuan to enhance the sales of traditional Chinese medicine materials in Yunnan Province and expand its business nationwide [1] Company Summary - Yunnan Baiyao's wholly-owned subsidiary, Yunnan Baiyao Group Chinese Medicine Resources Co., Ltd., will execute the acquisition in cash [1] - Ju Yao Tang specializes in the production and sales of traditional Chinese medicine pieces, toxic traditional Chinese medicine pieces, directly consumable traditional Chinese medicine pieces, and formula granules, demonstrating stable and continuous profitability [1]